Sangeeta Mukhi, Anindya Bose, Dilip Kumar Das, Sitansu Kumar Panda, Debahuti Mohapatra, S. Latha, Ashok Kumar Balaraman
Sangeeta Mukhi1, Anindya Bose1, Dilip Kumar Das2, Sitansu Kumar Panda3, Debahuti Mohapatra4, S. Latha5, Ashok Kumar Balaraman6
1Department of Pharmaceutical Analysis, School of Pharmaceutical Sciences, Siksha ‘O’ Anusandhan (Deemed to be University), Kalinga Nagar, Bhubaneswar - 751003, Odisha, India.
2Department of Pathology, Hi-Tech Medical College, Bhubaneswar, Odisha, India.
3Department of Anatomy, Institute of Medical Sciences and SUM Hospital, Siksha ‘O’ Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.
4Department of Pathology, Institute of Medical Sciences and SUM Hospital, Siksha ‘O’ Anusandhan (Deemed to be University), Kalinga Nagar, Bhubaneswar, Odisha, India.
5Department of Pharmaceutical Technology, Centre for Excellence in Nanobio Translational Research, Anna University, Bharathidasan Institute of Technology Campus, Tiruchirappalli, Tamil Nadu, India.
6Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia.
Volume - 14,
Issue - 6,
Year - 2021
Amrtadi Churna is an Ayurvedic polyherbal formulation containing three herbs viz., Amalaki (Emblica officinalis), Gokshur (Tribulus terrestris) and Guduchi (Tinospora cordifolia). It is prescribed in India for immunomodulation and treating hyperacidity. The present work reports the acute and sub-acute toxicity assessment of Amrtadi Churna on experimental animals to rule whether it might produce toxicity on herb-herb interactions by combining its ingredient. The results showed that, the single administration of high dose (5000 mg/kg) of the Churna neither induced mortality nor any adverse toxicity signs in rats, suggesting its practically non-toxic nature in the therapeutic doses. Sub-acute toxicity testing results of hematology, serum biochemistry and organ histology showed that the product did not induce any toxic signs at the tested dose levels. However, it produced an apparently harmless hyperbilirubinemia without any signs of liver damage. There were no major gender specific variations except a few hematological parameters. It was concluded that, Amrtadi Churna could be relatively safe at therapeutic dose levels, ruling out any serious side effects by the interaction of its three herbal ingredients.
Cite this article:
Sangeeta Mukhi, Anindya Bose, Dilip Kumar Das, Sitansu Kumar Panda, Debahuti Mohapatra, S. Latha, Ashok Kumar Balaraman. Acute and Sub-acute Toxicity study of Amrtadi Churna. Research Journal of Pharmacy and Technology. 2021; 14(6):3111-8. doi: 10.52711/0974-360X.2021.00543
Sangeeta Mukhi, Anindya Bose, Dilip Kumar Das, Sitansu Kumar Panda, Debahuti Mohapatra, S. Latha, Ashok Kumar Balaraman. Acute and Sub-acute Toxicity study of Amrtadi Churna. Research Journal of Pharmacy and Technology. 2021; 14(6):3111-8. doi: 10.52711/0974-360X.2021.00543 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-6-33
1. Che CT, Wang ZJ, Chow MSS, Lam CWK. (2013) Herb-Herb Combination for Therapeutic Enhancement and Advancement: Theory, Practice and Future Perspectives. Molecules. 2013; 18(5): 5125-5141.
2. Anonymous. Ayurvedic Formulary of India Part 3. New Delhi: Ministry of Health and Family Welfare, Department of AYUSH, Government of India. 2011; 1st ed.
3. Mukhi S, Bose A, Ray A, et al. Analytical Standards of Amrtadi Churna: A Classical Ayurvedic Formulation. Indian Journal of Pharmaceutical Sciences. 2017; 79(2): 227-240.
4. Abudayyak M, Jannuzzi AT, Ozhan G, et al. Investigation on the toxic potential of Tribulus terrestris in vitro. Pharmaceutical Biology. 2015; 53(4): 469-476.
5. Hemalatha S, Hari R. Acute and Sub-acute Toxicity Studies of the Saponin Rich Butanol Extracts of Tribulus terrestris Fruits in Wistar Rats. International Journal of Pharmaceutical Sciences Review and Research. 2014; 27(2): 307-313.
6. Jaijoy K, Soonthornchareonnon N, Lertprasertsuke N, et al. Acute and chronic oral toxicity of standardized water extract from the fruit of Phyllanthus emblica Linn. International Journal of Applied Research in Natural Products. 2010; 3(1): 48-58.
7. Devbhuti D, Gupta JK, Devbhuti P, et al. Phytochemical and acute toxicity study on Tinospora tomentosa Miers. Acta Poloniae Pharmaceutica. 2009; 66(1): 89-92.
8. Kansabanik S, Mukhi S, Das C, et al. Establishment of Quality Control Parameters of Nagarmotha Churna. Research Journal of Pharmacy and Technology. 2019; 12(12): 5967-5971.
9. Anonymous. OECD guidelines for testing of chemicals test no. 425: Acute oral toxicity – up-and-down procedure. OECD Publishing, Paris. 2008.
10. Anonymous. Guidelines for testing of chemical. Repeated dose 28-day oral toxicity study in rodents. OECD Publishing, Paris. 2008.
11. Parimalakrishnan S, Sundar VD, Ulaganathan I, et al. Preliminary Toxicity Evaluation of Bidens pilosa Extracts Using Experimental Mice. Research Journal of Pharmacognosy and Phytochemistry. 2010; 2(5): 397-402.
12. Anthony OE, Comfort MC, Chuka BD. Phytochemical Screening and Acute- and Organ- Toxicity Evaluation of Telfairia occidentalis Root Aqueous Extract on Normal Wister Rats. Research Journal of Pharmacognosy and Phytochemistry. 2010; 2(5): 417-420.
13. Hassan S., El-Twab SA, Hetta M, et al. Improvement of lipid profile and antioxidant of hypercholesterolemic albino rats by polysaccharides extracted from the green alga Ulva lactuca Linnaeus. Saudi Journal of Biological Sciences. 2011; 18(4): 333–340.
14. Baghel SS, Dangi S, Soni P, et al. Acute Toxicity Study of Aqueous Extract of Coccinia indica (Roots). Asian Journal of Pharmaceutical Sciences. 2011; 1(1): 23-25.
15. Kramer JA, O’Neill E, Phillips ME, et al. Early toxicology signal generation in the mouse. Toxicologic Pathology. 2010; 38(3): 452–471.
16. Asare GA, Gyan B, Bugyei K, et al. Toxicity potentials of the nutraceutical Moringa oleifera at supra-supplementation levels. Journal of Ethnopharmacology. 2012; 139(1): 265–272.
17. Anonymous. Harmonised integrated classification system for human health and environmental hazards of chemical substances and mixtures. Chapter 2.1, adopted 14th August 2001. OECD Publishing, Paris. 2001.
18. Kennedy GL, Ferenz RL, Burgess BA. Estimation of acute oral toxicity in rats by determination of the approximate lethal dose rather than the LD50. Journal of Applied Toxicology. 1986; 6(3): 145–148.
19. Ateba SB, Simo RV, Mbanya JC, et al. Safety profile and gender specific differences of a methanol extract of Eriosemala urentii (Leguminosae) in acute and subchronic (28 days) oral toxicity studies in Wistar rats. Food and Chemical Toxicology. 2014; 65: 27–32.
20. Parasuraman S. Toxicological screening. Journal of Pharmacology and Pharmacotherapeutics. 2011; 2(2): 74–79.
21. Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. Journal of Basic and Clinical Pharmacy. 2016; 7(2): 27-31.
22. Lee MY, Shin IS, Seo CS, et al. Sub chronic oral toxicity studies of the traditional herbal formula Bangpunglongseong-an in Crl:CD (SD) rats. Journal of Ethnopharmacology. 2012; 144(3): 720–725.
23. Teo S, Strlig D, Thomas S, et al. A 90 days oral gavage toxicity study of D-methylphenidate and D, L-methylphenidate in Sprague-Dawley rats. Toxicology. 2002; 179(3): 183–196.
24. Thanabhorn S, Jaijoy K, Thamaree S, et al. Acute and sub-acute toxicity study of the ethanol extract from Locinera japonica Thunb. Journal of Ethnopharmacology. 2006; 107(3): 370–373.
25. Mukinda JT, Syce JA. Acute and chronic toxicity of the aqueous extract of Artemisia afrain rodents. Journal of Ethnopharmacology. 2007; 112(1): 138-144.
26. Angele MK, Ayala A, Cioffi WG, et al. Testosterone: the culprit for producing splenocyte immune depression after trauma hemorrhage. American Journal of Physiology. 1998; 274(6): 1530-1536.
27. Ahmed SA, Hissong BD, Verthelyi D, et al. Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environmental Health Perspectives. 1999; 107(Suppl 5): 681–686.
28. Sin DD, Cohen SBZ, Day A, et al. Understanding the biological differences in susceptibility to chronic obstructive pulmonary disease between men and women. Proceedings of the American Thoracic Society. 2007; 4(8): 671–674.
29. Clarke EGC and Clarke ML. Veterinary Toxicology. Cassel and Collier Macmillan Publishers. 1997.
30. Ramaiah SK. A toxicologist guide to the diagnostic interpretation of hepatic biochemical parameters. Food and Chemical Toxicology. 2007; 45(9): 1551–1557.
31. Han YD, Song SY, Lee JH, et al. Multi enzyme-modified biosensing surface for the electrochemical analysis of aspartate transaminase and alanine transaminase in human plasma. Analytical and Bioanalytical Chemistry. 2011; 400(8): 797–805.
32. Ozer J, Ratner M, Shaw M, et al. The current state of serum biomarkers of hepatotoxicity. Toxicology. 2008; 245(3): 194-205.
33. VanWagner LB, Green RM. Evaluating Elevated Bilirubin Levels in Asymptomatic Adults. Journal of the American Medical Association. 2015; 313(5): 516–517.
34. Abudayyak M, Jannuzzi AT, Ozhan G, et al. Investigation on the toxic potential of Tribulus terrestris in vitro. Pharmaceutical Biology. 2015; 53(4): 469-476.
35. Dekant W, Vamvakas S. Biotransformation and membrane transport in nephrotoxicity. Critical Reviews in Toxicology. 1996; 26(3): 309–334.
36. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet. 2005; 365(9457): 417–447.
37. Kulkarni YA, Veeranjaneyulu A. Toxicological evaluation of the methanol extract of Gmelina arborea Roxb. Bark in mice and rats. Toxicology International. 2012; 19(2): 125-131.